Prescription Drug Information: MELOXICAM (Page 6 of 6)

PRINCIPAL DISPLAY PANEL — 7.5 MG

PRINCIPAL DISPLAY PANEL
(click image for full-size original)
Meloxicam 7.5mg unit dose label
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 15 MG

PRINCIPAL DISPLAY PANEL
(click image for full-size original)
MELOXICAM meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0615-8040(NDC:69097-158)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 7.5 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
MAGNESIUM STEARATE
SODIUM CITRATE
STARCH, CORN
CELLULOSE, MICROCRYSTALLINE
ANHYDROUS LACTOSE
Product Characteristics
Color yellow Score no score
Shape ROUND Size 8mm
Flavor Imprint Code C;158
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0615-8040-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE contains a BLISTER PACK
1 5 TABLET in 1 BLISTER PACK This package is contained within the BOX, UNIT-DOSE (0615-8040-30)
2 NDC:0615-8040-39 30 TABLET in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077929 07/19/2006
MELOXICAM meloxicam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0615-8124(NDC:69097-159)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
MELOXICAM (MELOXICAM) MELOXICAM 15 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
MAGNESIUM STEARATE
SODIUM STEARATE
Product Characteristics
Color yellow Score no score
Shape ROUND Size 10mm
Flavor Imprint Code CIPLA;159
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0615-8124-39 30 TABLET in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077929 07/19/2006
Labeler — NCS HealthCare of KY, LLC dba Vangard Labs (050052943)
Establishment
Name Address ID/FEI Operations
NCS HealthCare of KY, LLC dba Vangard Labs 050052943 repack (0615-8040), repack (0615-8124)

Revised: 03/2023 NCS HealthCare of KY, LLC dba Vangard Labs

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2024. All Rights Reserved.